Zhijun, Huang <br/><br/>
Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Aug 2016 
 - 10257-67 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-016-4868-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Benzamides--pharmacology<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Colorectal Neoplasms--pathology<br/>Enzyme-Linked Immunosorbent Assay<br/>Flow Cytometry<br/>Gene Knockdown Techniques<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Xenograft Model Antitumor Assays